News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Scios Inc. (JNJ) Announces Agreement with Department of Justice Regarding NATRECOR(R)



10/6/2011 11:13:44 AM

RARITAN, N.J., Oct. 5, 2011 /PRNewswire/ -- Today Scios Inc. announced an agreement with the United States Department of Justice to resolve allegations of misbranding of NATRECOR® (nesiritide), a prescription medication for patients with heart failure.

As part of this agreement, Scios Inc. entered a guilty plea to a single misdemeanor violation of the Food, Drug and Cosmetic Act, and agreed to pay an $85 million fine.

Scios acknowledges that NATRECOR® was misbranded and used in a way not approved by the U.S. Food and Drug Administration because its labeling lacked adequate directions for that use, but denies any wrongful intent in connection with this plea.

Contact:

Media:
Shaun Mickus
Office: (908) 927-2416
smickus@its.jnj.com

Bill Foster
Mobile: (908) 392-6057
wfoster@its.jnj.com

SOURCE Scios Inc.


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES